lenalidomidi

Lenalidomide is an immunomodulatory drug used in the treatment of certain cancers. It is an oral medication and is a derivative of thalidomide, but with a modified chemical structure that alters its pharmacological properties and side effect profile. Lenalidomide functions by affecting the immune system and has direct anti-cancer effects. It is believed to inhibit the growth of cancer cells and stimulate the body's immune response against them.

The primary approved uses for lenalidomide include the treatment of multiple myeloma, a type of blood cancer, in combination with other medications. It is also used for certain types of lymphoma, specifically mantle cell lymphoma and transfusion-dependent anemia due to myelodysplastic syndromes. The specific indications and treatment regimens can vary depending on the patient's condition and geographical region.

Lenalidomide is administered orally, usually as capsules. Due to its teratogenic potential, meaning it can cause severe birth defects, strict pregnancy prevention programs are mandatory for both male and female patients of reproductive potential. Patients must enroll in these programs and adhere to specific guidelines regarding contraception and pregnancy testing. Common side effects can include fatigue, low blood cell counts (anemia, neutropenia, thrombocytopenia), rash, and diarrhea. More serious side effects can occur, and patients are closely monitored by healthcare professionals during treatment.